On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

Ahead of a planned trial next month, Jazz Pharmaceuticals is moving to resolve antitrust allegations surrounding its key ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

After the success of a public service advertisement campaign aimed at improving recognition of the early signs of Alzheimer’s disease ...

Ask a healthcare professional (HCP) to name a psychiatric medicine and chances are they’ll say a brand approved at least 10 ...

Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...

Mucinex maker Reckitt Beckiser’s new “simpler and more effective organization” won’t include 190 New Jersey workers. | ...

A New York City federal court has dismissed a proposed class action lawsuit against Bristol Myers Squibb that accused the ...

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...

As the countdown to the launch of its first therapeutic continues, Rocket Pharmaceuticals is fueling up its commercial team.

After another solid year that included 12% growth in the top line, Vertex has bumped up its compensation for CEO Reshma ...

While the omission of pharmaceuticals from President Donald Trump’s much-anticipated reciprocal tariffs gave the industry a ...